StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Generic Competition (% pts cc) by Quarter

Generic Competition (% pts cc) (%)

QuarterlyAnnual

Novartis Generic Competition (% pts cc): -9.0% in Q3 2026, down 2.0 pts from a year earlier.

Latest, Q3 2026
-9.0%
Period ended Sep 30, 2026
Change on a year earlier
-2.0 pts
-7.0% in Q3 2025
History
13 quarters
Since Q3 2023
Sources
13
Documents cited below

Where the Q3 2026 figure comes from

“Net sales were USD 14.5 billion (+4%, +4% cc), with volume growth contributing 14 percentage points, partly offset by 9 percentage points from generic competition. Pricing had a negative impact of 1 percentage point, and currency had no impact.”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K (Operating Review).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGeneric Competition (% pts cc) (%)Year on yearSource
Q3 2026Sep 30, 2026-9.0%-2.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 2026-14.0%-12.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026-14.0%-12.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025-15.0%-14.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025-7.0%-5.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 2025-2.0%0.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 2025-2.0%0.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 2024-1.0%+2.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 2024-2.0%+2.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 2024-2.0%–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 2024-2.0%–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 2023-3.0%–Novartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 2023-4.0%–Novartis Form 6-K (0001370368-23-000068) ↗

Cite this data

StockData. (2026). Novartis Generic Competition (% pts cc) (%), quarterly Q3 2023–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/bridge-generic-pp

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.